Office or virtual visits typically occur every eight to twelve weeks
A patient or clinician can draw a fraction of a branded 2.5 mg tirzepatide vial, often starting around 0.5 mg, roughly a fifth of the lowest approved dose
By acting on key areas of the brain that regulate appetite and satiety, GLP-1 therapies help reduce hunger, curb cravings, and promote a sustained feeling of fullness
Weight loss may be associated with other symptoms, e.g., muscle loss, fatigue, menstrual changes, gallstones, and mood changes
(PubMed) Avoid if pregnant/breastfeeding, have liver/kidney disease, asthma or severe allergies, immune compromise, or if you cannot confirm product sterility and source
Expert Providers: Our skilled team includes board-certified providers with specialized expertise in metabolic health and tirzepatide therapy, ready to assist you